Pal Sutanaya, Jackson Daniel, McNamara Susan
SUNY Upstate Medical University
University of Louisville School of Medicine
Healthcare professionals have a key role in assessing the risk of suicide in patients. More than half of the individuals who died by suicide have seen a healthcare professional within the preceding year. Healthcare use by those who subsequently die by suicide is more common across all healthcare settings, including outpatient medical specialty clinics, primary care, inpatient hospitals, and emergency departments. Despite the awareness of suicide risk, assessing and managing this risk remains challenging for healthcare professionals, even though suicides are preventable using evidence-based interventions. However, "The estimation of suicide risk, at the culmination of the suicide assessment, is the quintessential clinical judgment, since no study has identified one specific risk factor or set of risk factors as specifically predictive of suicide or other suicidal behavior." Suicide is a leading cause of death worldwide. According to the World Health Organization, Suicide Worldwide in 2019more than 700,000 people died by suicide in 2019, and suicide is the fourth leading cause of death among adolescents and young adults aged 15 to 29. Suicide is a global health issue affecting all ages, sexes, and regions. A significant barrier to screening for suicide risk is the dilemma of how to care for patients who screen positive; every patient care setting needs a plan to manage cases like this. The National Institute of Mental Health Ask Suicide Questions (ASQ) Toolkit website is a free resource that provides tools to help providers in various settings identify individuals at risk for suicide and provides evidence-based clinical pathways for further interventions. Pathways for managing suicide risk can be described in 3 steps: Brief screening for suicide risk. Brief suicide safety assessment for patients who screen positive. Determining a course of action for patients who screen positive. The purpose of a brief screening for suicide risk is to identify patients at risk of suicide. Screening with evidence-based tools can be universal or targeted to higher-risk groups and may be incorporated into the electronic health record. Barriers to screening include concerns that asking about suicide risk can cause increased distress; worry about inordinate amounts of time to refer patients who screen positive to emergency or mental health services, causing disruptions in workflow; and negative patient reactions to screening. However, study results show that asking about suicide risk does not cause iatrogenic harm. Brief evidence-based interventions reduce immediate risk, and screening for suicide risk has broad support among patients and caregivers. Evidence-based screening tools include the Ask Suicide-Screening Questions, available in multiple languages; the Patient Safety Screener-3; and the Columbia-Suicide Severity Rating Scale, Screening Version, which are brief and easy to use. Depression screening alone is not adequate. Patients who screen positive should have a Brief Suicide Safety Assessment (BSSA) to clarify a patient's risk severity. This is not a full psychiatric assessment and takes 10 to 15 minutes; the BSSA, however, can help decide the next steps. The National Institute of Mental Health ASQ Toolkit website offers a toolkit that provides scripts and worksheets for BSSA of youths and adults in the emergency department, inpatient medical and surgical units, and outpatient settings, as well as a patient resource list. A 3-step process of screening, assessing, and disposition is effective in reducing the risk of patient suicide. Educational initiatives for primary care clinicians yield the most benefit since they encounter a significant portion of suicidal patients as the first point of contact. Clinicians across different healthcare settings can identify suicide risk and connect patients to further mental health care. BSSA has 3 possible scenarios that guide the next steps in caring for a patient who has revealed suicidal ideation or engaged in suicidal behavior: Patients at imminent risk or with acute positive screens need emergency psychiatric and safety evaluations; clinicians are obligated to ensure the patient's safety. Patients who are at moderate risk or require further evaluation need a prompt, comprehensive assessment from a mental health professional and interventions such as a safety plan, lethal means safety counseling, and access to crisis resources. Patients at mild risk may not require further evaluation but could benefit from mental health follow-up and developing a safety plan, as well as receiving a list of resources, such as the 988 Suicide and Crisis Lifeline number. .
医疗保健专业人员在评估患者自杀风险方面起着关键作用。超过一半的自杀死亡者在之前一年里曾看过医疗保健专业人员。随后自杀死亡者在所有医疗环境中的就医情况更为常见,包括门诊医疗专科诊所、初级保健机构、住院医院和急诊科。尽管人们已经意识到自杀风险,但对医疗保健专业人员来说,评估和管理这种风险仍然具有挑战性,尽管自杀是可以通过循证干预措施预防的。然而,“在自杀评估的最后阶段,对自杀风险的估计是典型的临床判断,因为没有研究确定一个特定的风险因素或一组风险因素能特别预测自杀或其他自杀行为。”自杀是全球主要的死亡原因之一。根据世界卫生组织的数据,2019年全球有超过70万人死于自杀,自杀是15至29岁青少年和年轻人中的第四大死因。自杀是一个影响所有年龄、性别和地区的全球健康问题。筛查自杀风险的一个重大障碍是如何照顾筛查呈阳性患者的困境;每个患者护理环境都需要一个管理此类病例的计划。美国国立精神卫生研究所自杀问题询问(ASQ)工具包网站是一个免费资源,提供工具以帮助不同环境中的医疗服务提供者识别有自杀风险的个体,并提供循证临床路径以进行进一步干预。管理自杀风险的路径可分为三个步骤:对自杀风险进行简短筛查。对筛查呈阳性的患者进行简短自杀安全评估。为筛查呈阳性的患者确定行动方案。对自杀风险进行简短筛查的目的是识别有自杀风险的患者。使用循证工具进行筛查可以是普遍的,也可以针对高风险群体,并且可以纳入电子健康记录。筛查的障碍包括担心询问自杀风险会导致更多痛苦;担心将筛查呈阳性的患者转诊到急诊或心理健康服务机构会花费过多时间,从而扰乱工作流程;以及患者对筛查的负面反应。然而,研究结果表明,询问自杀风险不会造成医源性伤害。基于证据的简短干预措施可降低即时风险,对自杀风险进行筛查在患者和护理人员中得到广泛支持。基于证据的筛查工具包括多种语言版本的自杀筛查问题询问、患者安全筛查器 - 3以及哥伦比亚自杀严重程度评定量表筛查版,这些工具简短且易于使用。仅进行抑郁症筛查是不够的。筛查呈阳性的患者应进行简短自杀安全评估(BSSA)以明确患者的风险严重程度。这不是全面的精神科评估, 需要10到15分钟;然而,BSSA可以帮助决定下一步措施。美国国立精神卫生研究所ASQ工具包网站提供了一个工具包,其中包含急诊科、住院医疗和外科病房以及门诊环境中针对青少年和成年人进行BSSA的脚本和工作表,以及一份患者资源清单。筛查、评估和处置的三步流程在降低患者自杀风险方面是有效的。针对初级保健临床医生的教育举措收益最大,因为他们作为第一接触点会遇到很大一部分自杀患者。不同医疗环境中的临床医生可以识别自杀风险并将患者转介至进一步的心理健康护理。BSSA有三种可能的情况,可指导对已表露自杀意念或实施自杀行为的患者进行护理的下一步措施:处于紧迫风险或急性阳性筛查结果的患者需要紧急精神科和安全评估;临床医生有义务确保患者安全。处于中度风险或需要进一步评估的患者需要心理健康专业人员进行及时、全面的评估以及诸如安全计划、致命手段安全咨询和获取危机资源等干预措施。轻度风险的患者可能不需要进一步评估,但可能会从心理健康随访、制定安全计划以及获取诸如988自杀与危机生命线号码等资源清单中受益。